Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Peter Joseph DeMaria"'
Autor:
Jennifer L. Marte, Katherine Lee-Wisdom, Renee N. Donahue, Charalampos S. Floudas, Ravi A. Madan, Borys Korchin, Caroline Jochems, Jeffrey Schlom, Angie Schwab, Jason M. Redman, Fatima Karzai, Claudia Palena, Peter Joseph DeMaria, Eva Dombi, James L. Gulley, Brigitte C. Widemann, Marijo Bilusic, Tatiana Adams, Julius Strauss, Cesar Pico-Navarro, Christopher R. Heery
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 9 (2021)
Journal for Immunotherapy of Cancer
Journal for Immunotherapy of Cancer
BackgroundMVA-BN-brachyury-TRICOM is a recombinant vector-based therapeutic cancer vaccine designed to induce an immune response against brachyury. Brachyury, a transcription factor overexpressed in advanced cancers, has been associated with treatmen
Autor:
James L. Gulley, Mohammad Hadi Bagheri, Seth M. Steinberg, Marijo Bilusic, Deric M. Park, Jennifer L. Marte, Renee N. Donahue, Mark R. Gilbert, Ravi A. Madan, Peter Joseph DeMaria, Julius Strauss, Victoria Shen, Christopher R. Heery, Jeffrey Schlom
Publikováno v:
The Oncologist
Background Brachyury is a transcription factor overexpressed in chordoma and is associated with chemotherapy resistance and epithelial‐to‐mesenchymal transition. GI‐6301 is a recombinant, heat‐killed Saccharomyces cerevisiae yeast‐based vac
Autor:
Marijo Bilusic, Ravi A. Madan, Fatima Karzai, Julius Strauss, Jennifer L. Marte, Katherine Lee-Wisdom, Renee N. Donahue, Jason M. Redman, Peter Joseph DeMaria, Charalampos S. Floudas, Borys Korchin, Houssein Abdul Sater, Tatiana Adams, Caroline Jochems, Jeffrey Schlom, Claudia Palena, James L. Gulley, Guenter Silbernagl, Cesar Pico-Navarro
Publikováno v:
Journal of Clinical Oncology. 39:2617-2617
2617 Background: Brachyury is a member of the T-box family of transcription factors which is overexpressed in several tumor types and has been associated with treatment resistance, epithelial to mesenchymal transition and metastatic potential. MVA-BN
Autor:
Marijo Bilusic, Renee N. Donahue, Jenn Marte, Peter Joseph DeMaria, Seth M. Steinberg, Mark R. Gilbert, Ravi A. Madan, Julius Strauss, James L. Gulley, Jeffrey Schlom, Christopher R. Heery, Deric M. Park
Publikováno v:
Journal of Clinical Oncology. 38:11527-11527
11527 Background: Chordoma is a rare neoplasm of the notochord that overexpresses brachyury, a transcription factor associated with epithelial-to-mesenchymal transition, metastasis, poor prognosis, and chemotherapy resistance. GI-6301 is a recombinan